The study assessed the density of CD3+ and CD8+ lymphocytes in resected specimens in the center of the tumor and in the invasive margin, finding that the levels of CD3+ lymphocytes in the center of the tumor were significantly higher in patients with low pre-treatment NLR than in patients with high pre-treatment NLR. The gene discussed is CD8A; the disease is neoplasm.